{"id":"metixene","rwe":[{"pmid":"41546927","year":"2026","title":"Metixene hydrochloride hydrate mitigates kidney tubulointerstitial fibrosis by inhibiting Smad3 phosphorylation.","finding":"","journal":"Experimental and molecular pathology","studyType":"Clinical Study"},{"pmid":"41270469","year":"2025","title":"Anti-prion drugs reduce endoplasmic reticulum stress and protect human dopaminergic neurons from death.","finding":"","journal":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","studyType":"Clinical Study"},{"pmid":"37847564","year":"2023","title":"Metixene is an incomplete autophagy inducer in preclinical models of metastatic cancer and brain metastases.","finding":"","journal":"The Journal of clinical investigation","studyType":"Clinical Study"},{"pmid":"35930306","year":"2023","title":"Molecular dynamics and docking studies on potentially active natural phytochemicals for targeting SARS-CoV-2 main protease.","finding":"","journal":"Journal of biomolecular structure & dynamics","studyType":"Clinical Study"},{"pmid":"33533011","year":"2021","title":"Anti-prion Drugs Targeting the Protein Folding Activity of the Ribosome Reduce PABPN1 Aggregation.","finding":"","journal":"Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics","studyType":"Clinical Study"}],"tags":[{"label":"metixene","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"5-hydroxytryptamine receptor 2C","category":"target"},{"label":"HTR2C","category":"gene"},{"label":"CHRM1","category":"gene"},{"label":"N04AA03","category":"atc"},{"label":"Active","category":"status"},{"label":"Parkinsonism","category":"indication"},{"label":"Novartis","category":"company"}],"phase":"marketed","safety":{},"trials":[],"aliases":[],"company":"Novartis","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=metixene","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:18:37.605242+00:00"},"timeline":{"url":"https://en.wikipedia.org/wiki/Metixene","method":"deterministic","source":"Wikipedia","rawText":"","confidence":0.8,"sourceType":"wikipedia","retrievedAt":"2026-04-20T00:18:44.760726+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:18:43.261416+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=metixene","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:18:43.634960+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201342/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:18:44.341750+00:00"}},"allNames":"metixen","offLabel":[],"synonyms":["methixene hydrochloride monohydrate","metixene","methixene","metixen","tremaril","tremonil","metixene hydrochloride","methixene hydrochloride","metixene HCl","methixene HCl"],"timeline":[],"approvals":[{"date":"","orphan":false,"company":"NOVARTIS","regulator":"FDA"}],"brandName":"Metixen","ecosystem":[{"indication":"Parkinsonism","otherDrugs":[{"name":"amantadine","slug":"amantadine","company":"Endo Pharms"},{"name":"benzatropine","slug":"benzatropine","company":""},{"name":"biperiden","slug":"biperiden","company":"Abbvie"},{"name":"carbidopa","slug":"carbidopa","company":"Merck Sharp Dohme"}],"globalPrevalence":null}],"mechanism":{"target":"5-hydroxytryptamine receptor 2C","novelty":"First-in-class","targets":[{"gene":"HTR2C","source":"DrugCentral","target":"5-hydroxytryptamine receptor 2C","protein":"5-hydroxytryptamine receptor 2C"},{"gene":"CHRM1","source":"DrugCentral","target":"Muscarinic acetylcholine receptor M1","protein":"Muscarinic acetylcholine receptor M1"}],"modality":"Small Molecule","drugClass":"metixene","explanation":"","oneSentence":"","technicalDetail":"Metixen acts as a selective antagonist at the 5-HT2C receptor, which is involved in the regulation of motor function and is implicated in the pathophysiology of Parkinsonism."},"_wikipedia":{"url":"https://en.wikipedia.org/wiki/Metixene","title":"Metixene","extract":"Metixene, also known as methixene, is an anticholinergic used as an antiparkinsonian agent. It has also been reported to induce incomplete autophagy and cell death in metastatic cancer and brain metastases."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1780","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=metixene","fields":["publications"],"source":"PubMed/NCBI"},{"id":3,"url":"https://en.wikipedia.org/wiki/Metixene","fields":["history","overview"],"source":"Wikipedia"}],"_enrichedAt":"2026-03-30T14:27:05.505899","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:18:46.034118+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"trihexyphenidyl","drugSlug":"trihexyphenidyl","fdaApproval":"1949-05-13","genericCount":10,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"biperiden","drugSlug":"biperiden","fdaApproval":"1959-09-08","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"procyclidine","drugSlug":"procyclidine","fdaApproval":"1955-07-27","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"profenamine","drugSlug":"profenamine","fdaApproval":"","relationship":"same-class"}],"genericName":"metixene","indications":{"approved":[{"name":"Parkinsonism","source":"DrugCentral","snomedId":32798002,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"trihexyphenidyl","brandName":"trihexyphenidyl","genericName":"trihexyphenidyl","approvalYear":"1949","relationship":"same-class"},{"drugId":"biperiden","brandName":"biperiden","genericName":"biperiden","approvalYear":"1959","relationship":"same-class"},{"drugId":"procyclidine","brandName":"procyclidine","genericName":"procyclidine","approvalYear":"1955","relationship":"same-class"},{"drugId":"profenamine","brandName":"profenamine","genericName":"profenamine","approvalYear":"","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"001765","UNII":"32VY6L26ZW","CHEBI":"CHEBI:51024","INN_ID":"1582","RXNORM":"258230","UMLSCUI":"C0066139","chemblId":"CHEMBL1201342","ChEMBL_ID":"CHEMBL1201342","KEGG_DRUG":"D01871","DRUGBANK_ID":"DB00340","PUBCHEM_CID":"4167","SNOMEDCT_US":"323245002","IUPHAR_LIGAND_ID":"7232","SECONDARY_CAS_RN":"7081-40-5","MESH_SUPPLEMENTAL_RECORD_UI":"C005111"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"","companyName":"Novartis","relationship":"Original Developer"}],"publicationCount":11,"therapeuticAreas":["Neuroscience"],"atcClassification":{"source":"DrugCentral","atcCode":"N04AA03","allCodes":["N04AA03"]},"biosimilarFilings":[],"originalDeveloper":"Novartis","recentPublications":[{"date":"2026 Mar","pmid":"41546927","title":"Metixene hydrochloride hydrate mitigates kidney tubulointerstitial fibrosis by inhibiting Smad3 phosphorylation.","journal":"Experimental and molecular pathology"},{"date":"2025 Dec","pmid":"41270469","title":"Anti-prion drugs reduce endoplasmic reticulum stress and protect human dopaminergic neurons from death.","journal":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"date":"2023 Dec 15","pmid":"37847564","title":"Metixene is an incomplete autophagy inducer in preclinical models of metastatic cancer and brain metastases.","journal":"The Journal of clinical investigation"},{"date":"2023 Aug-Sep","pmid":"35930306","title":"Molecular dynamics and docking studies on potentially active natural phytochemicals for targeting SARS-CoV-2 main protease.","journal":"Journal of biomolecular structure & dynamics"},{"date":"2021 Apr","pmid":"33533011","title":"Anti-prion Drugs Targeting the Protein Folding Activity of the Ribosome Reduce PABPN1 Aggregation.","journal":"Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"Novartis","companyId":"novartis","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"NOVARTIS","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":"NOVARTIS","brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":"NOVARTIS","brand_name_local":null,"application_number":null},{"country_code":"SA","regulator":"SFDA","status":"likely_approved","approval_date":null,"mah":"NOVARTIS","brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":"NOVARTIS","brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":"NOVARTIS","brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:18:46.034118+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":false,"score":1}}